Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Some chemotherapy can cause permanent hair loss.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

PLD is an effective and safer alternative for treating breast cancer.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Tufted folliculitis is common in patients with folliculitis decalvans.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.